This article presents . We will follow a hypothetical but representative IgG1 monoclonal antibody—let us call it "Mab-X"—through the four critical stages of bioprocess development: upstream processing (cell culture), downstream processing (purification), formulation, and scale-up. By examining the specific bottlenecks, optimization strategies, and analytical milestones of Mab-X, we will illustrate why bioprocess development is often the rate-limiting step in bringing lifesaving medicines to patients.
: Implementing risk management and real-time monitoring to ensure consistent quality throughout the product lifecycle. Key Stages in the A-Mab Bioprocess Development 1. Defining Critical Quality Attributes (CQAs) A Mab A Case Study In Bioprocess Development